A survey of people with mental illness has found more reports of discrimination than positive treatment while they were looking for work.
In the survey, 1386 people with diagnosed mental illness were asked about how they had been treated by various people including people in the workplace and educational institutions, friends, partners and other family members.
For most people and situations, being treated positively was more common than discrimination or avoidance. However, for people looking for work or in situations involving the legal system, banking or insurance, discrimination was more common.
Over half of people surveyed said that they had not been hired because of their mental illness. Survey participants mentioned negative responses after disclosing their mental illness:
“Once they heard that word that’s it. Sometimes I think it’s worse than telling them you’ve been in jail. Once you mention that their face changes and their body language changes and you know you won’t get the job”.
”I applied for a government job and they said the mental state wasn’t quite what they were looking for.”
The survey also asked participants about their experiences when they were employed. Among these 992 people, 11% reported being avoided, 14% reported being discriminated against and 24% reported being treated more positively.
The most common types of discrimination included having their illness treated dismissively or being shown a lack of understanding about how mental health problems affect behaviour and work performance.
”The HR manager doesn’t view it as an illness, views it as an attitude problem…”
” They put me down and laugh at it, they don’t believe in it.”
Other common experiences included being forced to change responsibilities or being denied opportunities, being fired or made redundant and being judged or treated as incompetent.
”A lot of people treat you like you’re completely and utterly a different person like they’ll slow things down for you and not in a positive way, like in a demeaning way, as if you’re a burden.”
The results weren’t all bad however, 25% of participants in the survey who were employed reported positive treatment. The most common positive experiences were being given flexible duties or hours worked, being allowed time off, having colleagues increase contact with them and encouragement to seek professional help.
Most research on negative attitudes towards mental illness focuses on asking people about their attitudes to people with mental illness. Studies exploring peoples’ experiences of discrimination are much less common and have tended to focus on one specific disorder or have only asked very brief questions.
The survey findings highlight the need to better support people with mental health problems who are looking for work, whether this is in supporting them to overcome anticipated discrimination or in other ways that support vocational rehabilitation, including education of employers. A recent review of workplace anti-stigma interventions found that effects were mixed, but generally positive.
This story is part of a series on mental illness and the workplace.
If you are distressed by this story or want to seek help for someone you know, please contact Lifeline 13 11 14 lifeline.org.au or SANE Australia 1800 187 263 sane.org/get-help
Nicola J Reavley receives funding from the National Health and Medical Research Council. She is affiliated with the Alliance for the Prevention of Mental Disorders.
Nicola J Reavley, Senior Research Fellow, Population Mental Health, University of Melbourne
This article was originally published on The Conversation. Read the original article.



Trump Hints at Major Autism Announcement, Raises Questions on Tylenol Link
U.S. Experts to Reassess Newborn Hepatitis B Vaccination Guidelines Amid Growing Debate
Major Drugmakers Slash U.S. Prices and Sell Directly to Patients Amid Trump’s Push for Affordable Medicines
Novartis to Acquire Avidity Biosciences for $12 Billion to Strengthen Rare Muscle Disorder Portfolio
Merck Nears Acquisition of Cidara Therapeutics at Significant Premium
Novo Nordisk Appoints Greg Miley to Lead Corporate Affairs Amid U.S. Drug Pricing Pressure
Eli Lilly’s Weight-Loss Pill Nears Fast-Track FDA Approval as Profits Surge on Global Demand
Innovent’s Xinermei Intensifies Weight-Loss Drug Battle in China
FDA Names Tracy Beth Høeg as Acting CDER Director After Richard Pazdur Announces Retirement
Canada Loses Measles-Free Status After Nearly 30 Years Amid Declining Vaccination Rates
Trump and Merck KGaA Partner to Slash IVF Drug Costs and Expand Fertility Coverage
Cogent Biosciences Soars 120% on Breakthrough Phase 3 Results for Bezuclastinib in GIST Treatment
Eli Lilly’s Inluriyo Gains FDA Approval for Advanced Breast Cancer Treatment
U.S. Reveals 2026 Medicare Star Ratings: Aetna, UnitedHealth Lead in Quality Scores
Novo Nordisk Appoints Greg Miley as Global Head of Corporate Affairs Amid U.S. Pricing Pressure 



